Skip to main content
Clinical Trials/CTRI/2018/07/014837
CTRI/2018/07/014837
Not yet recruiting
Phase 2

Evaluation Of Nebulized Dexmedetomidine As a premedication In Blunting Hemodynamic Response To Intubation

IZAMS INSTITUTE OF MEDICAL SCIENCES0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- controlled diabetics, normal patients, male and female , 18-60 years of age.Health Condition 2: E119- Type 2 diabetes mellitus without complications
Sponsor
IZAMS INSTITUTE OF MEDICAL SCIENCES
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
IZAMS INSTITUTE OF MEDICAL SCIENCES

Eligibility Criteria

Inclusion Criteria

  • 1\)ASA I ,II
  • 2\)Age group 18\- 60 yrs
  • 3\)male/female
  • 4\)patients with normal airway parameters.
  • 5\)Patients posted for elective surgeries under general anaesthesia with endotracheal intubation

Exclusion Criteria

  • 1\)ASA III,IV,V,VI.
  • 2\)patients with anticipated difficult intubation or difficult mask ventilation.
  • 3\)Patients with uncontrolled hypertension, cardiac disorders where haeodynamic responses to intubation may be not be tolerated .
  • 4\)Patients with poor pulmonary reserve where early desaturation is expected.
  • 5\)patients with active secreting adrenal tumors.
  • 6\)patients with large thyroid mass or other neck masses precipitating difficult airway.
  • 7\)Patients with BMI \> 30 kg/m2\.
  • 8\)Pediatric age group
  • 9\)pregnant females
  • 10\)C\-spine fracture or other cervical disorders with restricted neck movement or unstable cervical spine

Outcomes

Primary Outcomes

Not specified

Similar Trials